# Dose Efficacy in Adhesive Capsulitis

> **NCT06848374** · PHASE3 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 40 (estimated)

## Conditions studied

- Adhesive Capsulitis of the Shoulder

## Interventions

- **DRUG:** 40 mg Methylprednisolone
- **DRUG:** 80 mg Methylprednisolone

## Key facts

- **NCT ID:** NCT06848374
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06848374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06848374, "Dose Efficacy in Adhesive Capsulitis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06848374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*